A randomized control trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: The PROTEKT trial.

被引：0
|
作者：
Andrew, M [1 ]
机构：
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2116
引用
收藏
页码：492A / 492A
页数：1
相关论文
共 50 条
  • [1] An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial
    Massicotte, P
    Julian, JA
    Gent, M
    Shields, K
    Marzinotto, V
    Szechtman, B
    Chan, AK
    Andrew, M
    [J]. THROMBOSIS RESEARCH, 2003, 109 (2-3) : 101 - 108
  • [2] Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-ontological disease -: A randomized controlled trial
    Abdelkefi, A
    Ben Othman, T
    Kammoun, L
    Chelli, M
    Ben Romdhane, N
    Kriaa, A
    Ladeb, S
    Torjman, L
    Lakhal, A
    Achour, W
    Ben Hassen, A
    Hsaïri, M
    Ladeb, F
    Ben Abdeladhim, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 2004, 92 (03) : 654 - 661
  • [3] Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children
    Pelland-Marcotte, M. C.
    Amiri, N.
    Avila, M. L.
    Brandao, L. R.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (06):
  • [4] Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children
    Brandao, Leonardo R.
    Shah, Niketa
    Shah, Prakeshkumar S.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (03):
  • [5] Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: A randomized trial
    Das, SK
    Cohen, AT
    Edmondson, RA
    Melissari, E
    Kakkar, VV
    [J]. WORLD JOURNAL OF SURGERY, 1996, 20 (05) : 521 - 527
  • [6] The PREVAIL trial and low-molecular-weight heparin for prevention of venous thromboembolism
    Muir, Keith W.
    [J]. STROKE, 2008, 39 (07) : 2174 - 2176
  • [7] Low-Molecular-Weight Heparin for Prevention of Central Venous Catheterization-Related Thrombosis in Children
    Nameth, Sherrie
    [J]. CRITICAL CARE NURSE, 2018, 38 (04) : 75 - 76
  • [8] An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial
    Massicotte, P
    Julian, JA
    Gent, M
    Shields, K
    Marzinotto, V
    Szechtman, B
    Andrew, M
    [J]. THROMBOSIS RESEARCH, 2003, 109 (2-3) : 85 - 92
  • [9] Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial
    Misra, U. K.
    Kalita, J.
    Chandra, S.
    Kumar, B.
    Bansal, V.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (07) : 1030 - 1036
  • [10] Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin):: Results of a randomized controlled trial
    Wirth, T
    Schneider, B
    Misselwitz, F
    Lomb, M
    Tüylü, H
    Egbring, R
    Griss, P
    [J]. ARTHROSCOPY, 2001, 17 (04): : 393 - 399
12345